Skip to main content
logo
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.70
-1.25 (-4.17%)
At close: Jul 29, 2026

BIONET Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
2,0093,9343,252--
Market Cap Growth
-43.84%20.99%---
Enterprise Value
9602,8012,381--
Last Close Price
28.7056.2046.45--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
13.0125.4739.99--
PB Ratio
1.653.242.51--
P/TBV Ratio
1.663.242.51--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
6.2118.1329.28--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.01---
Net Debt / Equity Ratio
-0.86-0.86-0.94-0.99-1.11
Net Debt / EBITDA Ratio
9.959.9512.6413.56-
Net Debt / FCF Ratio
7.577.577.1111.3415.53
Asset Turnover
0.120.120.090.02-
Inventory Turnover
3.123.125.31--
Quick Ratio
18.9718.9723.0243.609.95
Current Ratio
19.7019.7023.7443.719.98
Return on Equity (ROE)
-7.76%-7.76%-9.46%-12.95%-
Return on Assets (ROA)
-5.53%-5.53%-6.57%-8.26%-
Return on Capital Employed (ROCE)
-9.50%-9.50%-7.70%-7.40%-25.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-4.85%-2.48%-2.65%--
FCF Yield
-6.90%-3.52%-5.26%--
Buyback Yield / Dilution
-21.88%-21.88%-280.50%-1278.45%-